These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 36333236)

  • 1. Epidemiology, Screening, and Prevention of Bladder Cancer.
    Lobo N; Afferi L; Moschini M; Mostafid H; Porten S; Psutka SP; Gupta S; Smith AB; Williams SB; Lotan Y
    Eur Urol Oncol; 2022 Dec; 5(6):628-639. PubMed ID: 36333236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of Bladder Cancer: A Systematic Review and Contemporary Update of Risk Factors in 2018.
    Cumberbatch MGK; Jubber I; Black PC; Esperto F; Figueroa JD; Kamat AM; Kiemeney L; Lotan Y; Pang K; Silverman DT; Znaor A; Catto JWF
    Eur Urol; 2018 Dec; 74(6):784-795. PubMed ID: 30268659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology, prevention, screening, diagnosis, and evaluation: update of the ICUD-SIU joint consultation on bladder cancer.
    Fernández MI; Brausi M; Clark PE; Cookson MS; Grossman HB; Khochikar M; Kiemeney LA; Malavaud B; Sanchez-Salas R; Soloway MS; Svatek RS; Vikram R; Vrieling A; Kamat AM
    World J Urol; 2019 Jan; 37(1):3-13. PubMed ID: 30105454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of Bladder Cancer in 2023: A Systematic Review of Risk Factors.
    Jubber I; Ong S; Bukavina L; Black PC; Compérat E; Kamat AM; Kiemeney L; Lawrentschuk N; Lerner SP; Meeks JJ; Moch H; Necchi A; Panebianco V; Sridhar SS; Znaor A; Catto JWF; Cumberbatch MG
    Eur Urol; 2023 Aug; 84(2):176-190. PubMed ID: 37198015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Tobacco Smoke in Bladder and Kidney Carcinogenesis: A Comparison of Exposures and Meta-analysis of Incidence and Mortality Risks.
    Cumberbatch MG; Rota M; Catto JW; La Vecchia C
    Eur Urol; 2016 Sep; 70(3):458-66. PubMed ID: 26149669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contemporary Occupational Carcinogen Exposure and Bladder Cancer: A Systematic Review and Meta-analysis.
    Cumberbatch MG; Cox A; Teare D; Catto JW
    JAMA Oncol; 2015 Dec; 1(9):1282-90. PubMed ID: 26448641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global burden of bladder cancer mortality in 2020 and 2040 according to GLOBOCAN estimates.
    Wéber A; Vignat J; Shah R; Morgan E; Laversanne M; Nagy P; Kenessey I; Znaor A
    World J Urol; 2024 Apr; 42(1):237. PubMed ID: 38625417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shortcomings in bladder cancer etiology research and a model for its prevention.
    Radosavljevic V; Belojevic G
    Tumori; 2014; 100(1):1-8. PubMed ID: 24675483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Environmental non-occupational risk factors associated with bladder cancer.
    Ferrís J; Berbel O; Alonso-López J; Garcia J; Ortega JA
    Actas Urol Esp; 2013 Oct; 37(9):579-86. PubMed ID: 23618510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and risk factors of urothelial bladder cancer.
    Burger M; Catto JW; Dalbagni G; Grossman HB; Herr H; Karakiewicz P; Kassouf W; Kiemeney LA; La Vecchia C; Shariat S; Lotan Y
    Eur Urol; 2013 Feb; 63(2):234-41. PubMed ID: 22877502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends.
    Antoni S; Ferlay J; Soerjomataram I; Znaor A; Jemal A; Bray F
    Eur Urol; 2017 Jan; 71(1):96-108. PubMed ID: 27370177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantified relations between exposure to tobacco smoking and bladder cancer risk: a meta-analysis of 89 observational studies.
    van Osch FH; Jochems SH; van Schooten FJ; Bryan RT; Zeegers MP
    Int J Epidemiol; 2016 Jun; 45(3):857-70. PubMed ID: 27097748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epidemiology of and risk factors for bladder cancer and for urothelial tumors].
    Guillaume L; Guy L
    Rev Prat; 2014 Dec; 64(10):1372-4, 1378-80. PubMed ID: 25668830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Factors Associated with Urothelial Bladder Cancer.
    Alouini S
    Int J Environ Res Public Health; 2024 Jul; 21(7):. PubMed ID: 39063530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bladder cancer risk: Use of the PLCO and NLST to identify a suitable screening cohort.
    Krabbe LM; Svatek RS; Shariat SF; Messing E; Lotan Y
    Urol Oncol; 2015 Feb; 33(2):65.e19-25. PubMed ID: 25044253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimates of the lead time in screening for bladder cancer.
    Benbassat J
    Urol Oncol; 2024 Apr; 42(4):110-114. PubMed ID: 38514215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bladder Cancer in Lebanon: Incidence and Comparison to Regional and Western Countries.
    Lakkis NA; Adib SM; Hamadeh GN; El-Jarrah RT; Osman MH
    Cancer Control; 2018; 25(1):1073274818789359. PubMed ID: 30027755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear matrix protein-22: a prospective evaluation in a population at risk for bladder cancer. Results from the UroScreen study.
    Huber S; Schwentner C; Taeger D; Pesch B; Nasterlack M; Leng G; Mayer T; Gawrych K; Bonberg N; Pelster M; Johnen G; Bontrup H; Wellhäusser H; Bierfreund HG; Wiens C; Bayer C; Eberle F; Scheuermann B; Kluckert M; Feil G; Brüning T; Stenzl A;
    BJU Int; 2012 Sep; 110(5):699-708. PubMed ID: 22313585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global Burden of Urologic Cancers, 1990-2013.
    Dy GW; Gore JL; Forouzanfar MH; Naghavi M; Fitzmaurice C
    Eur Urol; 2017 Mar; 71(3):437-446. PubMed ID: 28029399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology and Prevention of Prostate Cancer.
    Gandaglia G; Leni R; Bray F; Fleshner N; Freedland SJ; Kibel A; Stattin P; Van Poppel H; La Vecchia C
    Eur Urol Oncol; 2021 Dec; 4(6):877-892. PubMed ID: 34716119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.